Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Orexia Therapeutics logo — Developing orexin agonists and positive modulators for the t...

Orexia Therapeutics

Developing orexin agonists and positive modulators for the treatment of neurological disorders

Founded 2019 United Kingdom London, United Kingdom 5 employees Seed Biotechnology, Health Care

General Information

Company Name Orexia Therapeutics
Founded Year 2019
Location United Kingdom London, United Kingdom
Employees 5
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Orexia Therapeutics. To contact Orexia Therapeutics, visit orexiatherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Orexia Therapeutics compare?

A PDF of Orexia Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Orexia Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Orexia Therapeutics

Orexia is developing orexin receptor agonists for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the normal sleep-wake cycle Orexin, also called ‘hypocretin’, is a key regulator of wakefulness and REM sleep. We aspire to develop innovative medicines that address the full spectrum of orexin dysfunction in disease areas where there is high unmet clinical need. Orexia is designing novel oral small molecule OX2R agonists and positive modulators, which would influence orexin neurotransmission differently. Orexin agonists and positive modulators have the potential to treat a wide range of disorders which are inadequately treated today, most notably Narcolepsy Type 1 (NT1) which is caused by profound loss of orexin-producing neurons. NT1 is a chronic rare disease that usually starts during adolescence and is estimated to effect over 3 million people worldwide. Orexin agonists and positive modulators will directly address the underlying disease pathology of NT1, and may have the potential for greater efficacy and tolerability than current therapies. Orexia is founded by Medicxi in collaboration with Sosei Heptares and leverages their unique GPCR structure-based drug design (SBDD) capability for the discovery and development of promising drug candidates.

No funding data available for Orexia Therapeutics yet.

Orexia Therapeutics Alternatives & Competitors

Orexia Therapeutics vs
Quince Therapeutics
Quince Therapeutics United States

Dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases

Post-IPO Equity
25 employees
Biotechnology, Health Care
Orexia Therapeutics vs
Microbion Corporation
Microbion Corporation United States

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serio...

Venture round
16 employees
Biotechnology, Health Care

FAQ About Orexia Therapeutics

Developing orexin agonists and positive modulators for the treatment of neurological disorders
Orexia Therapeutics was founded in 2019.
Orexia Therapeutics is headquartered in London, United Kingdom.
Orexia Therapeutics operates in Biotechnology and Health Care.
Orexia Therapeutics has approximately 5 employees.
Top alternatives and competitors to Orexia Therapeutics include Quince Therapeutics, Microbion Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orexia Therapeutics and Quince Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Orexia Therapeutics, https://bouncewatch.com/company/orexia-therapeutics, updated 17 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes